|
Sponsored by the EC Framework VI, Food Quality and Safety
Development and employment of validated methods for the screening and testing of Pharmaceutical Products (PPs) and their metabolites, to identify potential endocrine disruptors, determine their adverse effects, origin, fate, and mechanism of action and to assess their risk on men and women fecundity in various geographical locations and exposure scenarios in Europe. WIT will mainly be involved with risk assessment for PPs in food and correlation analysis between exposure to endocrine-active chemicals in food and other sources and markers of fecundity in the study populations. WIT is the leader of the Work Package: Risk assessment of pharmaceutical products in food based on regional, socio-economic and gender factors.
The Wessex Institute of Technology is carrying out this project in association with:
- Analyst Research Laboratories Ltd., Israel
- The Volcani Center, Israel
- The National Institute for Public Health, Netherlands
- Aarhus University Hospital, Denmark
- INRA-CNRS -Physiologie de la Reproduction & des Comportements, France
- Centre Universitaire-UFR Biomédicale, France
- Factline Webservices GmbH, Austria
- OSM-DAN Ltd., Israel
For further information please click here.
 Exposure pathways of pharmaceutical products that may end up in the human food chain. |
